These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 7747155

  • 21. Metabolic studies in kidney stone disease.
    Wong SY, Slater SR, Evans RA, Mason R, Lancaster EK, Acland SM, Eade Y, Hills E, Dunstan CR.
    Q J Med; 1992 Mar; 82(299):247-58. PubMed ID: 1631259
    [Abstract] [Full Text] [Related]

  • 22. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Okawa T.
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [Abstract] [Full Text] [Related]

  • 23. Urinary citrate in kidney stone disease.
    Usui Y, Matsuzaki S, Matsushita K, Shima M.
    Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
    [Abstract] [Full Text] [Related]

  • 24. [Indication of the urinary citrate levels in idiopathic renal calculosis].
    Jaeger P, Portmann L, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Mar 22; 116(12):371-3. PubMed ID: 3961456
    [Abstract] [Full Text] [Related]

  • 25. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Mar 22; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 26. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr 22; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 27. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium-protein intake and vitamin D metabolism].
    Lalau JD, Achard JM, Bataille P, Bergot C, Jans I, Boudailliez B, Petit J, Henon G, Westeel PF, el Esper N.
    Ann Med Interne (Paris); 1992 Apr 22; 143(5):293-8. PubMed ID: 1482031
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.
    Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ.
    Hum Mol Genet; 2008 Jun 01; 17(11):1613-8. PubMed ID: 18276610
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
    Hofbauer J, Höbarth K, Zechner O.
    Z Urol Nephrol; 1990 Nov 01; 83(11):597-602. PubMed ID: 2100085
    [Abstract] [Full Text] [Related]

  • 33. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, Stefoni S.
    J Nephrol; 2003 Nov 01; 16(2):260-6. PubMed ID: 12768074
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A correlation and path coefficient analysis of components of calciuria in normal subjects and idiopathic stone formers.
    Puche RC, Carlomagno AF, Gonzalez A, Sanchez A.
    Bone Miner; 1987 Aug 01; 2(5):405-11. PubMed ID: 3505767
    [Abstract] [Full Text] [Related]

  • 36. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
    Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML.
    J Urol; 1996 Sep 01; 156(3):907-9. PubMed ID: 8709360
    [Abstract] [Full Text] [Related]

  • 37. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R, Vescini F.
    Arch Ital Urol Androl; 2009 Sep 01; 81(3):182-7. PubMed ID: 19911682
    [Abstract] [Full Text] [Related]

  • 38. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG, Berg C, Fornander AM, Nilsson MA.
    Scanning Microsc; 1993 Mar 01; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [Abstract] [Full Text] [Related]

  • 39. Fasting and post-calcium load serum calcium, parathyroid hormone, calcitonin, in male idiopathic calcium urolithiasis--evidence for a basic disturbance in calcium metabolism.
    Schwille PO, Rümenapf G, Schmidtler J, Köhler R.
    Exp Clin Endocrinol; 1987 Aug 01; 90(1):71-5. PubMed ID: 3666061
    [Abstract] [Full Text] [Related]

  • 40. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Urology; 2004 Oct 01; 64(4):833-8. PubMed ID: 15491743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.